Physician profile
Benjamin Blais
NPI 1760869309
$5,448.12
in general payments reported to CMS, 2019-2025
7 companies · $1,740 in 2025
The $1,740 reported for 2025 was more than what 84% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.06 · 2021: $139 · 2022: $290 · 2023: $1,867 · 2024: $1,379 · 2025: $1,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,265 · Food and Beverage: $1,530 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,265.04 |
| Food and Beverage | $1,529.58 |
| Education | $191.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,155.97 | 2021-2025 | Harmony |
| W. L. Gore & Associates, INC. | $1,824.43 | 2023 | Gore Cardioform Septal Occluder |
| Edwards Lifesciences Corporation | $187.27 | 2021-2022 | |
| Abbott Laboratories | $118.30 | 2024 | Amplatzer Piccolo |
| Cook Medical LLC | $109.31 | 2024 | Profusion Therapeutic Infusion Needle |
| B. Braun Interventional Systems INC. | $33.06 | 2020 | |
| Boston Scientific Corporation | $19.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Blais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.